Categories Technology, U.S. Markets News

Former Oracle product chief Thomas Kurian replaces Diane Greene as Google Cloud CEO

Google Cloud’s CEO Diane Greene announced in a blog post that she will be stepping down from her role and former Oracle (ORCL) executive Thomas Kurian will be succeeding her. Thomas will be joining the company on November 26. Greene will continue as CEO till January 2019 to ensure the smooth transition. She will remain as a Director of the Alphabet (GOOG, GOOGL) board.

Thomas Kurian replaces Diane Greene as Google Cloud CEO

After joining Google’s Board in 2012, Diane joined Google full time in December 2015 as CEO of Google Cloud. Prior to Google, Diane co-founded and ran three successful technology companies: VMware. VXtreme and bebop, an enterprise SaaS startup acquired by Google.

Google’s CEO Sundar Pichai said, “In a few short years, under Diane’s leadership, Cloud has become an incredible business built on Google’s decades of investment in infrastructure, data security, and AI.”

Google also witnessed another key executive’s resignation this week. According to Synced, Google Cloud AI’s Jia Li, who joined in 2016, resigned as head of research and development on Wednesday. During her three years with Google, Jia Li advanced the implementation of AI-enabled products on the Google Cloud Platform.

Thomas Kurian replaces Diane Greene as Google Cloud CEO

Thomas Kurian, who has got 22 years of experience at Oracle, most recently served as President of Product Development in Oracle and resigned in September 2018. Before resigning from Redwood City, California-based company, Kurian was taking an extended time off. Reports stated that he had a difference of opinion with founder Larry Ellison over Oracle’s cloud business.

 

After drone program, Google opts out of Pentagon’s cloud service contract

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips

 

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top